4,0
25. Feb. 2022
Aktueller Mitarbeiter, mehr als 10 Jahre
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Great benefits, great people to work with. State of the art instruments that provide so much for patients.
Kontras
Pay raises below standard, with inflation this year and record profits Roche made, raises across nation are very low and was really discouraging to field workers who have been holding this company up while most haven't left their house in two years. Field workers have had to work insane hours and install a ton of instruments so the pay raises to appreciate this would have been nice, given the billions made. We are short staffed greatly already so worried this is going to cause even more Field Engineers to leave now.